URGENT: SAFE Drugs Act is in play, risking patients
The anti-compounding SAFE Drugs Act would gut the ability of compounders to fill in during drug shortages — and is showing momentum in the Senate.
Being an exceptional compounding professional means you never stop learning
We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
The anti-compounding SAFE Drugs Act would gut the ability of compounders to fill in during drug shortages — and is showing momentum in the Senate.
There is a smart third way for PCAC and the FDA to handle peptides other than “keep them banned” and “legalize them all.”
Elections for the APC board are coming up — if you're thinking of running, we've got a briefing for you
Some quick news bites from around the compounding pharmacy world
We need to be face to face with the senators and representatives who will be voting on the SAFE Act and the future of compounding.